Ginkgo Bioworks Holdings DNA
NYSE DNA
$11.49 -0.27 (-2.30%)
As of: Oct 14, 2026 · 3:13 PM EDT

Ginkgo Bioworks Holdings (DNA) Asset Writedowns and Impairment (2022 - 2024)

Updated

Ginkgo Bioworks Holdings (DNA) recorded Asset Writedowns and Impairment of $47.9 million in FY2024.

Analysis

Ginkgo Bioworks Holdings (DNA) Asset Writedowns and Impairment (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.58 Bn 35.29 Bn 1.44 Bn
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn
3 Charles River Laboratories International 14.53 Bn 13.73 Bn 363.37 Mn
4 Icon 13.23 Bn 10.34 Bn 479.29 Mn
5 Fortrea Holdings 2.01 Bn 1.39 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 712.22 Mn -49.86 Mn 18.44 Mn
7 Evotec SE 502.55 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 64.01 Mn 27.66 Mn 1.61 Mn
10 Natural Alternatives International 6.63 Mn -21.45 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 47.90 Mn
Dec 31, 2022 -10.10 Mn
API Access

Ginkgo Bioworks Holdings Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=DNA&period=max&api_key=YOUR_API_KEY